Management of Peripheral T-cell Lymphomas and the Role of Transplant.
Management of Peripheral T-cell Lymphomas and the Role of Transplant.
复制标题
DOI:
10.1007/s11912-022-01310-3
复制
发表时间:
2022-11
影响因子:
4.7
通讯作者:
中科院分区:
文献类型:
--
作者:
Peripheral T-cell lymphomas are a rare subset of non-Hodgkin lymphomas that are treated with curative intent. While therapy has been based on other aggressive lymphoid malignancies, outcomes are generally poorer than B-cell lymphomas with 5-year overall and progression free survival 30–40% and 20–30%, respectively. In effort to improve outcomes, transplant has been used in both the frontline and salvage settings. Although not studied in randomized studies, consolidation with autologous stem cell transplant in first remission has been associated with an approximately 50–60% 5-year overall survival and 40–45% 5-year progression free survival. Unfortunately, most patients relapse, and, in this setting, allogeneic transplant remains the only curative option for those who are transplant eligible. Multiple series have now shown that 3-year overall survival with allogeneic transplant is approximately 60%. However, outcomes with transplant are associated with disease control at the time of transplant.
登录
查看更多内容
影响因子:
10.1
作者:
Bellei M;Foss FM;Shustov AR;Horwitz SM;Marcheselli L;Kim WS;Cabrera ME;Dlouhy I;Nagler A;Advani RH;Pesce EA;Ko YH;Martinez V;Montoto S;Chiattone C;Moskowitz A;Spina M;Biasoli I;Manni M;Federico M;International T-cell Project Network
通讯作者:
International T-cell Project Network
DOI:
10.1016/j.annonc.2021.12.002
发表时间:
2022-03
期刊:
Annals of oncology : official journal of the European Society for Medical Oncology
影响因子:
--
作者:
通讯作者:
--
影响因子:
4.3
作者:
Chen, Andy I.;McMillan, Alex;Neprin, Robert S.;Horning, Sandra J.;Laport, Ginna G.
通讯作者:
Laport, Ginna G.
影响因子:
28.5
作者:
Foss F;Horwitz S;Pro B;Prince HM;Sokol L;Balser B;Wolfson J;Coiffier B
通讯作者:
Coiffier B
影响因子:
13.8
作者:
Du J;Yu D;Han X;Zhu L;Huang Z
通讯作者:
Huang Z